TB500 5MG (Thyomosin Beta 4) – 5MG per vial

Clinical Test Expectation TB500 5MG- Human Subjects : Formation of new blood vessels leading to anti-inflammation and wound healing. Hair growth Strength - 5MG per vial

Introduction TB500 5MGis a synthetic peptide version of the naturally occurring healing protein present in about all human and mammalian cells known as Thymosin Beta 4 (TB4). Research has shown TB 500 to have beneficial effects on wound healing, injury recovery, flexibility, and inflammation. These desirable effects are accomplished through TB 500’s influence on blood cell and blood vessel development, cellular differentiation, and cell migration. A major part of its healing capability stems from the peptide’s regulation of actin, a cell building protein essential to healing and wound repair.

Dosing Details You inject 1ml water into the vial of TB500 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial and inject it into the tummy under the skin into the fatty skin layer. The dose is 5mg for the one shot.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation GHK-cu - Human Subjects : Wound healing and antiaging skin care ++. Antioxidant and Anti-Inflammatory Properties. Stimulates Blood Vessel Growth. Increases Neurotrophins. Gene Regulator. Reverse Gene Silencing Strength - 100MG per vial

Introduction The human peptide GHK-cu (glycyl-l-histidyl-l-lysine) has multiple biological actions, all of which, according to our current knowledge, appear to be health positive. It stimulates blood vessel and nerve outgrowth, increases collagen, elastin, and glycosaminoglycan synthesis, as well as supports the function of dermal fibroblasts. GHK’s ability to improve tissue repair has been demonstrated for skin, lung connective tissue, boney tissue, liver, and stomach lining. GHK has also been found to possess powerful cell protective actions, such as multiple anti-cancer activities and anti-inflammatory actions, lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts, suppression of molecules thought to accelerate the diseases of aging such as NFκB, anti-anxiety, anti-pain and anti-aggression activities, DNA repair, and activation of cell cleansing via the proteasome system. Recent genetic data may explain such diverse protective and healing actions of one molecule, revealing multiple biochemical pathways regulated by GHK.

Dosing Details You inject 2ml water into the vial of GHK cu from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear blue in colour you draw out 20 (2 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 10 days.

Clinical Test Expectation LL-37 - Human Subjects : Antibiotic resistant infections. Immune system booster. Staphylococcus Aureus bacteria barrier. Beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus. Strength - 5MG per vial

Introduction LL-37 is an antimicrobial peptide (AMP) that belongs to the cathelicidin family and serves as an alternative to antibiotics. An AMP can eliminate the bugs, regulate bacterial invasions, and control infections and inflammation. The peptide is naturally produced within the body through various tissues and circulates throughout different cells including bone marrow cells, epithelial cells and gastrointestinal tract cells. However, if the body doesn’t produce enough, it becomes vulnerable to bad bacteria, eventually causing it to accumulate pathogens and create chronic diseases and inflammation. Peptides contain amino acids that release certain proteins to focus on refining certain bodily functions. LL-37 contains approximately 12-80 amino acids with the purpose of assisting patients build immunity and fight contagious viruses.

Peptide LL-37 acts as the first line of defense when the body is suffering from injuries, infections, wounds or inflammation. Because of this, the peptide is useful in treating those suffering from tick-borne illnesses such as Lyme, RMSF, Anaplasmosis, Babesiosis and Colorado Tick Fever. Other research has shown that the peptide is effective in treating conditions such as diabetes, E. Coli, Candida Albicans, and certain types of cancer. While it’s mostly known for its anti-biofilm, the peptide also plays a critical role in regulating inflammatory molecules and contains healing properties to damaged tissues. This is especially beneficial for those who suffer with autoimmune disease, Inflammatory Bowel Disease, arthritis or Lupus.

Dosing Details You inject 2ml water into the vial of LL-37 from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 30 (3 units) on the syringe each night before bed and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation Gonadorelin - Human Subjects : In males - Delayed puberty. Infertility in males caused by pituitary or hypothalamus problems. In females - cause ovulation (release of an egg from the ovary) in women who do not have regular ovulation and menstrual periods Strength - 5MG per vial

Introduction Gonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.

Dosing Details : You inject 2ml water into the vial of Gonadorelin from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 20 (2 units) on the syringe each morning before breakfast and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7 days

Clinical Test Expectation - Tirzepatide - Human Subjects : Aids type 2 diabetis. Assist with large scale weight loss. Strength - 2MG per vial

Introduction Historically, the treatment of obesity focused almost exclusively on lifestyle-based approaches. However, evidence that diet and exercise prompt physiological counterregulatory mechanisms that limit weight reduction and impede weight maintenance has led to the realization that obesity is a complex, multicomponent metabolic disease of energy homeostasis involving central and peripheral mechanisms. Once obesity is present, those mechanisms render a return to lower weight difficult. Accordingly, several clinical guidelines now recommend treatment with antiobesity medications for people with obesity or for those with overweight and weight-related complications. Recent studies with long-acting glucagon-like peptide-1 (GLP-1) receptor agonists demonstrated that greater efficacy with acceptable safety could be achieved by targeting the pathways of endogenous nutrient-stimulated hormones. Glucose-dependent insulinotropic polypeptide (GIP), another nutrient-stimulated hormone, regulates energy balance through cell-surface receptor signaling in the brain and adipose tissue. A molecule that combines both GIP and GLP receptor agonism theoretically may lead to greater efficacy in weight reduction.

Tirzepatide is a once-weekly subcutaneous injectable peptide (approved by the Food and Drug Administration [FDA] for type 2 diabetes) engineered from the native GIP sequence, with agonist activity at both the GIP and GLP-1 receptors. Preclinical data demonstrated that the affinity of tirzepatide for GIP receptors was equal to the affinity of native GIP for GIP receptors, whereas tirzepatide bound GLP-1 receptors with affinity approximately five times weaker than native GLP-1 bound GLP-1 receptors. GIP activation appeared to act synergistically with GLP-1 receptor activation to allow greater weight reduction in humans than that achieved with GLP-1 receptor monoagonism. In phase 2 studies in people with type 2 diabetes, tirzepatide induced clinically relevant weight reduction, warranting further investigation for the treatment of obesity. The present trial, SURMOUNT-1, evaluated the efficacy and safety of tirzepatide in adults with obesity or overweight who did not have diabetes with great success

Dosing Details You inject 1ml water into the vial of Tirzepatide from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out the entire vial and inject it into the tummy under the skin into the fatty skin layer. A vial should last 1 usage once a week.

How long will a vial last ? A vial should last 7 days.

Clinical Test Expectation Hexarelin - Human Subjects :Lean muscle growth. Rapid fat loss. Increased tendon and ligament strength. Enhanced flexibility. Better recovery. Cardiovascular aid Strength - 2MG per vial

Introduction Hexarelin is used to stimulate natural growth hormone production, promoting lean muscle growth, rapid fat loss, increased tendon and ligament strength, enhanced flexibility, and better recovery from injuries and training sessions. Hexarelin, a synthetic growth hormone-releasing peptide, can bind to and activate the growth hormone secretagogue receptor (GHSR) in the brain similar to its natural analog ghrelin. However, the peripheral distribution of GHSR in the heart and blood vessels suggests that hexarelin might have direct cardiovascular actions beyond growth hormone release and neuroendocrine effects. Furthermore, the non-GHSR CD36 had been demonstrated to be a specific cardiac receptor for hexarelin and to mediate its cardioprotective effects. When compared with ghrelin, hexarelin is chemically more stable and functionally more potent. Therefore, it may be a promising therapeutic agent for some cardiovascular conditions.

Dosing Details You inject 2ml water into the vial of Hexarelin from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out 20 (2 units) on the syringe each night before bed and inject it into the tummy under the skin into the fatty skin layer.

How long will a vial last ? A vial should last 7 days.